GURU.Markets stock price, segment price, and overall market index valuation
The company's share price RCEL
AVITA Medical produces the RECELL device for treating burns and skin defects using a patient's own cells. Its stock price reflects the pace of adoption of this innovative technology in hospitals and its expansion into new indications.
Share prices of companies in the market segment - Therapeutic medical equipment
AVITA Medical produces and markets the RECELL system, which allows doctors to create a spray from a patient's own skin cells to treat burns and wounds. We classify it as a "Therapeutic Medical Device" because it offers a breakthrough technology in regenerative medicine. The graph below shows the dynamics of this innovative sector.
Broad Market Index - GURU.Markets
AVITA Medical produces and markets the RECELL system, which uses a patient's own cells to regenerate skin from burns and wounds. Its unique technology makes it part of the GURU.Markets index. The chart below compares its price history with the overall market.
Change in the price of a company, segment, and market as a whole per day
RCEL - Daily change in the company's share price RCEL
AVITA Medical's daily volatility is measured by change_co. It reflects its sensitivity to the commercial success of its burn and wound treatment technology. This metric is important for analyzing the medical technology sector on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Therapeutic medical equipment
AVITA Medical, Inc. is a regenerative medicine company. This chart highlights the high volatility of the MedTech sector. Comparison with RCEL, which focuses on burn treatment, helps to assess it as an innovative player.
Daily change in the price of a broad market stock, index - GURU.Markets
AVITA Medical has developed a "spray-on skin" technology for burn treatment. It is an innovative company in the regenerative medicine sector. Its stock price reflects progress in the implementation of breakthrough medical technologies and is part of the overall market volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization RCEL
For AVITA Medical, Inc., the year-over-year performance is a story of commercialization of its RECELL system for burn and wound treatment. Its market cap growth over the past 12 months reflects the growing number of hospitals using its technology, which creates a "skin spray" for rapid healing—its key advantage.
Annual dynamics of market capitalization of the market segment - Therapeutic medical equipment
AVITA Medical, Inc. is a regenerative medicine company that has developed a system for treating burns using a patient's own cells. This chart shows how its innovative technology, growing hospital adoption, and expansion into new indications are impacting its performance in the sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
AVITA, with its skin regeneration technology, is a growth story in medicine. Its stock price is driven not by economics, but by the adoption rate of its burn and wound treatment products. The chart reflects the potential of this breakthrough technology, which could become a new standard in this field.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization RCEL
AVITA Medical is commercializing its spray-on skin technology for burn treatment. Its monthly price dynamics reflect the pace of hospital adoption. Quarterly reports on RECELL system sales growth and news of geographic expansion or new approvals are the main drivers visible on this chart.
Monthly dynamics of market capitalization of the market segment - Therapeutic medical equipment
This chart illustrates the dynamics of the medical technology sector. For AVITA, with its innovative spray-on skin technology, it provides context. Its movements reflect demand for its products from burn centers and its success in expanding indications.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
AVITA Medical produces the RECELL system for skin regeneration in burns and wounds using the patient's own cells. The company's growth depends on the implementation of its technology. A full-market chart allows you to assess how strong its growth trend, driven by medical innovation, allows AVITA shares to move independently of overall market sentiment.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization RCEL
AVITA Medical shares reflect weekly progress in the treatment of burns and skin defects. The price dynamics of this company, which produces a skin regeneration system, reflect the pace of its adoption in burn centers and the expanding indications for this innovative technology.
Weekly dynamics of market capitalization of the market segment - Therapeutic medical equipment
AVITA Medical offers innovative solutions for skin regeneration. The company's success in the medical device sector depends on the implementation of its technologies in clinics and regulatory approval. This chart helps distinguish whether AVITA's share price fluctuations are driven by unique commercial successes or by general trends in the therapeutic device industry.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
AVITA Medical produces equipment for regenerative medicine. Demand for its products is driven by medical needs, not the state of the economy. The chart below will help you determine whether AVITA shares are truly a "safe haven" asset, demonstrating stability amid market uncertainty.
Market capitalization of the company, segment and market as a whole
RCEL - Market capitalization of the company RCEL
AVITA Medical's market capitalization tells the story of its commercialization of skin regeneration technology for burn treatment. The chart reflects its transition from development to sales. Its dynamics reflect the market's assessment of its RECELL system as a new standard of care and its potential for expansion into other areas, such as vitiligo treatment.
RCEL - Share of the company's market capitalization RCEL within the market segment - Therapeutic medical equipment
AVITA Medical has developed the RECELL System, a technology that produces a spray from a patient's own skin cells for the treatment of burns and wounds. Its market share reflects its innovative approach to regenerative medicine. The chart below shows how this technology fits into the current practice of treating severe skin injuries.
Market capitalization of the market segment - Therapeutic medical equipment
AVITA Medical offers a unique skin regeneration technology for the treatment of burns and wounds. The chart below shows the overall market capitalization of the medical device sector. Its growth reflects the continued demand for innovative treatments, and AVITA's technology is a prime example of this breakthrough.
Market capitalization of all companies included in a broad market index - GURU.Markets
AVITA Medical has developed a "sprayable skin" technology (RECELL System) for burn treatment. The company's market capitalization reflects a breakthrough in regenerative medicine. The company's growth on the overall chart demonstrates how innovative approaches are changing treatment standards and helping people recover from severe injuries.
Book value capitalization of the company, segment and market as a whole
RCEL - Book value capitalization of the company RCEL
AVITA Medical's book value is its capital, which supports the commercialization of the RECELL system for treating burns and wounds using a patient's own cells. This is a real, technological foundation for regenerative medicine. How has this innovative medical asset grown? The chart below shows its development dynamics.
RCEL - Share of the company's book capitalization RCEL within the market segment - Therapeutic medical equipment
AVITA Medical manufactures a skin regeneration device used for burns at its dedicated facility. The graph shows the share of this unique manufacturing asset in the sector, reflecting the physical foundation behind its revolutionary technology.
Market segment balance sheet capitalization - Therapeutic medical equipment
AVITA Medical produces skin regeneration equipment. This requires certified production facilities. The book value chart shows the real assets behind this innovative medical technology and how they are growing.
Book value of all companies included in the broad market index - GURU.Markets
AVITA Medical develops skin regeneration technology. The company's book value is derived from its production facilities for the RECELL system, its laboratories, and its global logistics network. The chart shows the physical weight of this medical company, whose assets literally help restore the human body.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - RCEL
AVITA Medical owns manufacturing plants, but the market values its unique RECELL skin regeneration technology over these. The chart shows the "innovation premium": how much more valuable investors value its patented technology and its potential to become a standard in burn treatment than its manufacturing assets.
Market to book capitalization ratio in a market segment - Therapeutic medical equipment
AVITA Medical has developed a skin spray technology for treating burns and wounds. Its value lies in this unique medical technology. The chart shows the premium the market is willing to pay for an innovative product that could change treatment standards, compared to the company's asset value.
Market to book capitalization ratio for the market as a whole
AVITA Medical has developed a skin regeneration system used in burn treatment. The technology creates a spray from the patient's own cells to restore skin. The company's value lies in its unique product. This chart shows the overall market valuation, but how do investors view this technology that is changing the standard for treating severe injuries?
Debts of the company, segment and market as a whole
RCEL - Company debts RCEL
For AVITA Medical, a company with a commercially successful skin regeneration product, the financial strategy is focused on market expansion. This chart shows how the company is using capital to expand its sales force and conduct marketing campaigns to accelerate the adoption of its technology in clinics worldwide.
Market segment debts - Therapeutic medical equipment
AVITA Medical offers an innovative skin regeneration technology for treating burns and wounds using a spray made from the patient's own cells. Commercializing such a product requires investment in production and physician training. This chart shows how the company is funding its expansion into the medical device market.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio RCEL
AVITA Medical produces medical equipment for burn treatment. This chart shows how the company uses debt financing to expand production and marketing of its products. For investors, this indicates how aggressively the company pursues growth and market penetration, balancing investment in sales with financial stability.
Market segment debt to market segment book capitalization - Therapeutic medical equipment
AVITA Medical offers skin regeneration technology for the treatment of burns and wounds. This chart shows the overall debt burden in the therapeutic medical device sector. It allows one to assess how companies in this niche are financing the commercialization of their products and how AVITA Medical's financial strategy compares to industry norms.
Debt to book value of all companies in the market
AVITA Medical offers an innovative burn treatment technology. Like many companies in the medical device sector, it requires investment in production and marketing. This graph of the market's total debt load allows one to assess whether the company is using debt capital for expansion or relying on its own cash flow and shareholders' equity.
P/E of the company, segment and market as a whole
P/E - RCEL
This metric for AVITA Medical, the developer of the RECELL skin regeneration system, demonstrates investor valuation of its burn and wound treatment technology. The multiple reflects expectations for the system's expanded use and adoption as a standard of care, which could drive significant revenue and profit growth for the company.
P/E of the market segment - Therapeutic medical equipment
Regenerative medicine, where AVITA Medical offers its burn treatment system, is a growing market. This chart shows the average valuation for medical device companies. It helps understand how investors view AVITA's technology and its potential to become a standard of care for burns and other skin defects.
P/E of the market as a whole
AVITA Medical produces the RECELL system, which uses a patient's own skin cells to treat burns and wounds. It's an innovative technology in regenerative medicine. This chart, showing the overall market "temperature," helps us understand whether AVITA Medical is valued for its unique, standard-changing product or whether its value is following general medical technology trends.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company RCEL
AVITA Medical produces the regenerative technology RECELL for the treatment of burns and skin defects. This chart shows market expectations for the expanded use of its product. The trend reflects sales growth forecasts due to approval of new indications and expansion into international markets.
%20P%2FE%20RCEL&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-RCEL&v=1772565732786 "Chart of the company's future (projected) P/E RCEL")
Future (projected) P/E of the market segment - Therapeutic medical equipment
AVITA Medical offers the RECELL System regenerative technology for the treatment of burns and other skin defects. This chart reflects profitability expectations in the therapeutic device sector. It helps understand whether investors believe the company's innovative approach to wound healing will set a new standard and drive above-market growth.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Therapeutic-medical-equipment&v=1772565732823 "Future (projected) P/E graph of the market segment - Therapeutic medical equipment")
Future (projected) P/E of the market as a whole
AVITA Medical develops and markets regenerative products for wound and burn treatment, most notably the RECELL skin regeneration system. This chart reflects the overall sentiment in the healthcare sector. For a company offering innovative regenerative medicine technology, it reflects the market's willingness to invest in new treatment standards.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772565732897 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit RCEL
AVITA Medical has developed the RECELL System technology for treating burns and skin defects using the patient's own cells. Commercial success, as demonstrated by this graph, depends on the implementation of this innovative system in hospitals and burn centers. This trend reflects how cutting-edge regenerative medicine is becoming a profitable business.
Profit of companies in the market segment - Therapeutic medical equipment
AVITA Medical has developed the RECELL System, a technology that creates a spray from a patient's own skin cells to treat burns and other wounds. This innovative solution accelerates healing and improves outcomes. This graph illustrates how breakthrough medical devices can change treatment standards and deliver high profitability in their respective segments.
Overall market profit
AVITA Medical offers revolutionary RECELL technology for burn treatment, enabling skin regeneration. Implementing such advanced medical devices in hospitals requires significant investment. This chart, reflecting the overall health of the corporate sector, indirectly indicates the healthcare system's financial capacity to purchase innovative equipment.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company RCEL
AVITA Medical produces the RECELL system, which is used to treat burns and other skin defects using the patient's own cells. The revenue forecast in this chart reflects analysts' expectations for the increased adoption of this innovative technology in hospitals and its expanded use in treating other types of wounds and scars.
%20profit%20of%20the%20company%20RCEL&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-RCEL&v=1772565733119 "Graph of future (projected) profit of the company RCEL")
Future (predicted) profit of companies in the market segment - Therapeutic medical equipment
AVITA Medical offers the innovative RECELL System technology for the treatment of burns and other skin defects, using the patient's own cells for skin regeneration. This graph shows the revenue forecast for the therapeutic medical device sector, helping to assess how AVITA's unique product can change treatment standards and capture market share.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Therapeutic-medical-equipment&v=1772565733187 "Graph of future (predicted) profits of companies in a market segment - Therapeutic medical equipment")
Future (predicted) profit of the market as a whole
AVITA Medical produces regenerative products for the treatment of burns and skin defects. Demand for its technology depends on the budgets of hospitals and healthcare systems. This graph, by predicting the overall economic situation, indirectly influences the funding levels of medical institutions and their ability to purchase innovative equipment.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772565733264 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - RCEL
AVITA Medical has developed a spray-on skin technology for burn treatment. This chart shows how investors estimate the revenue from this innovative technology. The high sales estimate reflects the potential of its RECELL system to become a new standard in regenerative medicine for skin restoration.
P/S market segment - Therapeutic medical equipment
AVITA Medical has developed an innovative skin regeneration technology, the RECELL System, which uses a small sample of a patient's skin to create a spray for treating burns and wounds. This chart shows the average market capitalization to revenue ratio for the medical equipment sector. It reflects how the market perceives the potential of this breakthrough technology to change the standard of skin damage treatment.
P/S of the market as a whole
AVITA Medical offers a regenerative technology—the RECELL system—that uses a patient's own skin cells to treat burns and wounds. It's an innovative approach to skin restoration. This chart shows how the market values medical device companies whose technologies have the potential to revolutionize treatment standards in their field.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company RCEL
AVITA Medical offers skin regeneration technology for the treatment of burns and wounds. This chart shows the company's valuation relative to its projected future sales. It reflects investor expectations for the expanded use of its RECELL system and its potential to become a standard of care in burn and dermatology.
%20P%2FS%20RCEL&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-RCEL&v=1772565733559 "The graph of the company's future (projected) P/S RCEL")
Future (projected) P/S of the market segment - Therapeutic medical equipment
AVITA Medical offers the RECELL System skin regeneration technology, used to treat severe burns and other skin defects. This innovative solution accelerates healing. This chart shows how the market assesses the future sales potential of this unique medical technology compared to other companies in the medical equipment sector.
%20P%2FS%20market%20segment%20graph%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Therapeutic-medical-equipment&v=1772565733663 "Future (projected) P/S market segment graph - Therapeutic medical equipment")
Future (projected) P/S of the market as a whole
AVITA Medical offers regenerative technology for the treatment of burns and skin defects. Demand for its products depends on their adoption in medical practice. This general expectations graph is of indirect significance for RCEL. Economic growth ensures stable funding for healthcare systems, which facilitates the adoption of new, effective technologies.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772565733674 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales RCEL
This graph shows the commercialization of cutting-edge medical technology. For AVITA Medical, it reflects demand for the RECELL® system, which is used to treat burns and skin defects using the patient's own cells. The trend demonstrates the successful implementation of this innovative product in hospitals.
Sales of companies in the market segment - Therapeutic medical equipment
AVITA Medical offers the RECELL System, a regenerative skin healing technology for treating burns and wounds. The expanding use of this system in hospitals is driving the company's growth. This graph shows the market for therapeutic equipment, and AVITA's success in commercializing its innovative product directly increases its market size.
Overall market sales
AVITA Medical offers skin regeneration technology for the treatment of burns and other wounds. Demand for its RECELL system reflects the introduction of innovations into surgical practice. The company's growth is an indicator of the development of the medical equipment sector, which improves quality of life and is an important, high-tech part of the modern economy.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company RCEL
AVITA Medical offers the innovative RECELL System skin regeneration technology for the treatment of burns and other skin defects. The company's future sales depend on its implementation in burn centers and hospitals worldwide. This graph reflects expected growth in the regenerative medicine market and the adoption of this advanced technology.
%20sales%20of%20the%20company%20RCEL&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-RCEL&v=1772565733962 "Schedule of future (projected) sales of the company RCEL")
Future (projected) sales of companies in the market segment - Therapeutic medical equipment
AVITA Medical offers regenerative technology for the treatment of burns and skin defects. The forecast for the therapeutic medical equipment sector demonstrates the demand for innovative treatment methods. It helps us understand how the company's RECELL system fits into the overall trend toward accelerated healing and improved clinical outcomes.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Therapeutic-medical-equipment&v=1772565734011 "Schedule of future (projected) sales of companies in the market segment - Therapeutic medical equipment")
Future (projected) sales of the market as a whole
AVITA Medical produces the RECELL System, a device for treating burns and skin defects using a patient's own cells. Demand for the product depends on medical needs. However, the overall economic situation, as reflected here, can impact hospital budgets and their willingness to implement new, albeit more effective, treatment technologies, which is essential for the company's growth.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772565734142 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality RCEL
AVITA Medical produces the RECELL system, used to treat burns and skin defects using a patient's own cells. The company's profitability depends on the volume of use of this innovative technology in hospitals. This chart shows how successfully AVITA is commercializing its product, turning medical procedures into financial returns.
Market segment marginality - Therapeutic medical equipment
AVITA Medical produces the RECELL system for treating burns and other skin defects using the patient's own cells. Profitability depends on the adoption of this technology by hospitals and surgeons. This metric demonstrates how effective the company's business model is compared to other manufacturers of therapeutic medical equipment.
Market marginality as a whole
AVITA Medical, Inc. produces the RECELL system for treating burns and other skin defects using the patient's own cells. This chart shows average profitability. In this context, AVITA is a story of commercialization of medical technology. Its path to profitability depends on widespread adoption of its system in hospitals and reimbursement from insurance companies.
Employees in the company, segment and market as a whole
Number of employees in the company RCEL
AVITA Medical has revolutionized burn treatment with its RECELL system. The growth of its sales team, visible in this chart, directly reflects the product's successful adoption in hospitals. Increasing the number of sales and training specialists is essential to expanding the use of this innovative skin regeneration technology.
Share of the company's employees RCEL within the market segment - Therapeutic medical equipment
AVITA Medical has revolutionized the treatment of burns and skin defects with its RECELL system. This figure reflects its dominance in the regenerative medicine niche and demonstrates the significant number of clinical specialists, medical engineers, and burn specialists the company brings together in this specialized field of healthcare.
Number of employees in the market segment - Therapeutic medical equipment
AVITA Medical has developed a spray-on skin technology for treating burns and wounds. This graph illustrates the growth in the regenerative medicine sector. The company's growth, particularly in its commercial operations, reflects the process of bringing an innovative product to market that could become a new standard in the treatment of skin injuries.
Number of employees in the market as a whole
AVITA Medical offers innovative solutions for burn treatment. This chart shows the overall employment situation, but for AVITA Medical, the key growth driver is the widespread adoption of its technology in hospitals. Successful implementation and regulatory approvals directly stimulate the hiring of sales and training specialists, creating a microtrend.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company RCEL (RCEL)
AVITA Medical produces the RECELL system for treating burns and skin defects using the patient's own cells. This chart shows how the market values this innovative medical device. The high market capitalization per employee reflects not the scale of production, but the uniqueness of the technology, which is changing treatment standards and has strong growth potential in the global market.
%20of%20the%20company%20RCEL%20(RCEL)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-RCEL-RCEL&v=1772565734771 "Chart of market capitalization per employee (in thousands of dollars) of the company RCEL (RCEL)")
Market capitalization per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
AVITA Medical produces equipment for regenerative medicine. The balance between the R&D team, which creates the technology, and the staff involved in production and sales is crucial. This chart helps assess how effectively the company scales its innovations while maintaining a high market value per employee.
%20by%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Therapeutic-medical-equipment&v=1772565734915 "Market capitalization per employee (in thousands of dollars) by market segment - Therapeutic medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
AVITA Medical produces the RECELL system, which is used to treat burns and other skin defects using the patient's own cells. This chart reflects the market's valuation of a company with a unique regenerative technology that could become a new standard of care, creating high added value per employee.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772565734958 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company RCEL (RCEL)
AVITA Medical is the company behind the RECELL system, which allows doctors to use a patient's own skin cells to treat burns and wounds. It's an innovative medical technology. This chart shows how successful the commercialization is. It measures how much revenue each employee (primarily the sales and physician training team) generates by promoting this regenerative technology in hospitals.
%20Chart%20RCEL%20(RCEL)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-RCEL-RCEL&v=1772565735012 "Company Profit Per Employee (in thousands of dollars) Chart RCEL (RCEL)")
Profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
AVITA Medical offers regenerative solutions for burn treatment (the RECELL system). In the medical equipment industry, this chart demonstrates the benchmark for team performance. AVITA's effectiveness depends on how successfully their sales team convinces clinics to adopt the new technology. Each employee must generate maximum revenue to justify the investment in this innovative therapy.
%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Therapeutic-medical-equipment&v=1772565735155 "Chart of profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
AVITA Medical has revolutionized burn treatment with the RECELL system. This is a medical equipment business where profit per employee depends on two factors: the effectiveness of R&D and, more importantly, the strength of the sales team. This graph shows how successfully their sales representatives are winning over hospitals and burn centers, scaling up sales of their innovative product.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772565735282 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee RCEL (RCEL)
AVITA Medical produces a system for treating burns and skin defects. This chart demonstrates the commercial success of its medical technology. It measures the sales volume generated by each employee in the commercial and production departments. This increase indicates broader adoption of the system in hospitals and the effectiveness of its sales strategy.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-RCEL-RCEL&v=1772565735390 "Sales chart per company employee RCEL (RCEL)")
Sales per employee in the market segment - Therapeutic medical equipment
AVITA Medical is known for its RECELL technology, which uses a patient's own cells to treat burns and wounds. This is a revolutionary approach in regenerative medicine. This chart shows how effectively their sales and clinical support teams are implementing this technology in hospitals, generating revenue from every kit sold.
Sales per employee for the market as a whole
AVITA Medical is a medical equipment company. Their flagship product is the RECELL system, which uses a patient's own cells to treat burns and wounds. This graph shows how much revenue each employee generates. It reflects the company's commercial performance: how successfully their team (R&D, sales) is promoting this innovative device to hospitals and burn centers.
Short shares by company, segment and market as a whole
Shares shorted by company RCEL (RCEL)
AVITA Medical produces the RECELL system, which uses a patient's own skin cells to treat burns and wounds. This chart highlights bearish bets. Bears may doubt that this technology will become a standard of care and replace traditional methods, or that the pace of its adoption in hospitals will be too slow to meet investor expectations.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-RCEL-RCEL&v=1772565735501 "Short Shares Chart for the Company RCEL (RCEL)")
Shares shorted by market segment - Therapeutic medical equipment
AVITA Medical is known for its RECELL System technology, which uses a "spray" of a patient's own cells to treat burns and wounds. This chart shows overall short positions in the medical equipment sector. If it's high, investors may be concerned that hospitals are cutting their budgets for new equipment purchases or that regulators (like the FDA) are tightening requirements.
Shares shorted by the overall market
AVITA Medical (RCEL) produces a "spray-on-skin" (RECELL) for burn treatment. It's an important medical product. But when this chart shows rising fears, investors worry that hospitals will cut budgets during a recession. They may prefer older, cheaper burn treatment methods over purchasing the expensive, innovative RCEL system.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator RCEL (RCEL)
AVITA Medical produces a spray-on skin (RECELL) for burn treatment. Business depends on hospital adoption of the technology. A chart above 70 may reflect strong growth in procedures or expanded indications. A chart below 30 may be due to slow adoption, competition, or reimbursement issues.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-RCEL-RCEL&v=1772565735753 "RSI 14 indicator chart for the company's stock RCEL (RCEL)")
RSI 14 Market Segment - Therapeutic medical equipment
AVITA (RCEL) is a "skin spray." Their system (RECELL) allows doctors to extract your cells in 30 minutes, "dissolve" them, and spray them on a burn for regeneration. The RSI_14_Seg for their segment (medtech) shows whether the sector is overbought. This helps us determine whether RCEL's growth is their niche or a general sign of overheating.
RSI 14 for the overall market
AVITA Medical (RCEL) produces a "skin spray" for burn treatment. This chart shows that its business is "defensive." Demand for severe burn treatment isn't driven by euphoria or panic—it's emergency medicine. During times of market panic, investors seek safe havens in companies with non-cyclical demand.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast RCEL (RCEL)
AVITA Medical (RCEL) produces the RECELL system, which uses a patient's own skin cells to treat severe burns and wounds. This graph shows the average 12-month prognosis. It reflects analysts' expectations for the implementation of this technology in burn centers and its expansion into new indications.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-RCEL-RCEL&v=1772565735850 "A chart showing analyst consensus forecasts for the expected stock price. RCEL (RCEL)")
The difference between the consensus estimate and the actual stock price RCEL (RCEL)
AVITA Medical has revolutionized burn treatment. Their RECELL system allows doctors to take a small sample of a patient's healthy skin and "disperse" its cells for regeneration. This chart shows the upside and downside potential analysts see in the stock. It measures the gap between the price and the forecast, reflecting their confidence in the technology's implementation.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-RCEL-RCEL&v=1772565735946 "A chart showing the difference between the consensus forecast and the actual stock price. RCEL (RCEL)")
Analyst consensus forecast for stock prices by market segment - Therapeutic medical equipment
AVITA Medical (RCEL) is a medical company that produces the RECELL system. It allows doctors to use a tiny sample of a patient's skin to create a "spray" of cells for burn treatment. This chart shows the overall expectations for the therapeutic medical device sector, reflecting experts' confidence in this skin regeneration technology.
Analysts' consensus forecast for the overall market share price
AVITA Medical (RCEL) is the company behind the "skin spray" (RECELL). Their technology allows them to extract a patient's (burn victim's) own cells and "spray" them onto the wound for regeneration. This chart shows the overall market sentiment. For AVITA, with their breakthrough technology, it's important to understand how these expectations (hospital budgets) influence the adoption of their product. (347)
AKIMA index of the company, segment and market as a whole
AKiMA Company Index RCEL
AVITA Medical is the creator of the skin spray gun. Their RECELL system allows doctors to take a tiny sample of healthy skin from a patient (for example, with burns), treat it, and spray it onto the wound for rapid regeneration. This graph is a summary indicator of their razor and blade products. It reflects their ability to sell razors (devices) and their growing, high-margin revenue from blades (consumables) for each procedure.
AKIMA Market Segment Index - Therapeutic medical equipment
AVITA Medical is known for its RECELL system, which uses small samples of a patient's skin to create a spray for treating severe burns and wounds. This graph shows the average index for the therapeutic equipment sector. It allows you to evaluate how well AVITA's innovative skin regeneration technology compares to the industry average.
The AKIM Index for the overall market
AVITA Medical is a regenerative medicine company known for its RECELL system for treating burns and wounds using the patient's skin cells. This chart, reflecting the market average, provides context. It helps assess how this commercial MedTech story stacks up against general economic trends and expanding indications.
